Next Article in Journal
Dynamics of Mycobacterium tuberculosis Lineages in Oman, 2009 to 2018
Previous Article in Journal
Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant
Previous Article in Special Issue
Ex Vivo Infection of Human Placental Explants by Trypanosoma cruzi Reveals a microRNA Profile Similar to That Seen in Trophoblast Differentiation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Host–Pathogen Interaction Involved in Trypanosoma cruzi Infection

by
Christian Castillo
1,2 and
Ulrike Kemmerling
1,*
1
Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile
2
Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago 7500975, Chile
*
Author to whom correspondence should be addressed.
Pathogens 2022, 11(5), 540; https://doi.org/10.3390/pathogens11050540
Submission received: 23 April 2022 / Accepted: 3 May 2022 / Published: 4 May 2022
(This article belongs to the Special Issue Host-Pathogen Interaction Involved in Trypanosoma cruzi Infection)
Chagas disease, or American trypanosomiasis, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is a silent, underdiagnosed, and life-threatening disease. Moreover, it constitutes a significant public health issue in Latin America and worldwide.
The probability of acquiring the disease depends on multiple factors: the parasite, the vectors, the mammalian hosts (including human beings), and socioeconomic aspects. In addition, the host–pathogen interaction is a key factor determining the probability of infection and the establishment of the disease. Thus, studying these different aspects is essential to understanding the pathogenesis of the disease and improving the diagnostic and therapeutic tools for T. cruzi infection. Therefore, several articles address these issues in the Special Issue “Host-Pathogen Interaction Involved in T. cruzi Infection” in Pathogens.
A state-of-the-art review of molecular and clinical aspects of chronic manifestation in Chagas disease is part of the Special Issue [1]. This review addresses the parasite’s life cycle, genetic diversity, virulence factors, infective mechanisms, and the epidemiology, clinical presentation, diagnosis, and treatment options of the principal chronic complications of Chagas disease.
In addition, a review of the liver and its immune responses against T. cruzi infection is also part of the Special Issue [2]. Here, the authors present the first paper published approaching the liver’s participation in parasite infection and subsequent articles published in the last century, including recently published results. It is proposed that, after infection, activated peripheral T lymphocytes reach the liver and induce a shift to a pro-inflammatory ambient environment. Thus, there is an immunological integration and cooperation between peripheral and hepatic immunity, contributing to disease control.
This Special Issue includes several original articles. A study about the role of the muscarinic acetylcholine receptor on mice behavior and brain lesions induced by T. cruzi is included [3]. Thus, the muscarinic cholinergic pathway seems to be involved in immune-mediated cell invasion events, while its blockade favors infection, brain lesions, and behavioral alterations. Furthermore, since acute chagasic encephalitis is a clinically severe central nervous system manifestation, this paper contributes to the knowledge of the nervous form of Chagas disease.
Another original paper is about congenital Chagas disease, responsible for 22.5% of new cases each year. Interestingly, placental transmission occurs in only 5% of infected mothers, and it has been proposed that the epithelial turnover of the trophoblast can be considered a local placental defense against the parasite and imply a critical control of gene expression that is regulated, among other mechanisms, by small non-coding RNAs such as microRNAs. A paper regarding T. cruzi-induced trophoblast epithelial turnover shows that placenta-specific miR-512-3p and miR-515-5p at least partially mediate trophoblast differentiation [4]. In addition, both miRNAs determine placental susceptibility to ex vivo infection of human placental explants. Knowledge about the role of parasite-modulated microRNAs in the placenta might enable their use as biomarkers as prognostic and therapeutic tools for congenital Chagas disease.
Moreover, studies about insect vectors are part of the Special Issue. Transmission patterns of vector-borne diseases are known to respond to habitat changes adaptively; as such, a study evaluated how the physical characteristics of Triatoma dimidiata would vary in relation to land use in El Salvador [5]. The authors suggest that mitigation studies of Chagas disease should exploit the relationships between anthropogenic land use and T. dimidiata morphology to evaluate how the transmission pattern of T. cruzi and Chagas disease symptomatology are impacted.
Another study focuses on understanding the blood meal patterns of insects that are vectors for T. cruzi. Knowledge about transmission dynamics is crucial for developing strategies to impede or decrease human–vector contact [6]. Thus, the authors determined the diversity of hosts that serve as blood sources for triatomines in domestic, peridomestic, and sylvatic transmission cycles in two endemic areas of Ecuador. The results showed that humans are the primary food source for triatomines, indicating that human–vector contact is more frequent than previously thought. On the other hand, the diversity of blood sources might indicate a preference driven by triatomine species. Moreover, more than one source of blood in triatomines collected in the same place indicates that dispersal of vectors occurs regardless of food availability. Therefore, the dispersal capacity of triatomines needs to be evaluated to propose an effective strategy that limits human–vector contact and, in consequence, decreases the risk of T. cruzi transmission.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Medina-Rincón, G.J.; Gallo-Bernal, S.; Jiménez, P.A.; Cruz-Saavedra, L.; Ramírez, J.D.; Rodríguez, M.J.; Medina-Mur, R.; Díaz-Nassif, G.; Valderrama-Achury, M.D.; Medina, H.M. Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review. Pathogens 2021, 10, 1493. [Google Scholar] [CrossRef] [PubMed]
  2. Vacani-Martins, N.; Meuser-Batista, M.; dos Santos, C.d.L.P.; Hasslocher-Moreno, A.M.; Henriques-Pons, A. The Liver and the Hepatic Immune Response in Trypanosoma cruzi Infection, a Historical and Updated View. Pathogens 2021, 10, 1074. [Google Scholar] [CrossRef] [PubMed]
  3. de Assis, G.M.P.; Donato, M.F.; Milagre, M.M.; Béla, S.R.; Ricci, M.F.; Batista, L.A.; de Lima, M.E.; Moreira, F.d.A.; Arantes, R.M.E.; de Lana, M. Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain. Pathogens 2021, 10, 121. [Google Scholar] [CrossRef] [PubMed]
  4. Medina, L.; Guerrero-Muñoz, J.A.; Liempi, A.I.; Castillo, C.; Ortega, Y.; Sepúlveda, A.; Salomó, F.; Maya, J.D.; Kemmerling, U. Ex Vivo Infection of Human Placental Explants by Trypanosoma cruzi Reveals a microRNA Profile Similar to That Seen in Trophoblast Differentiation. Pathogens 2022, 11, 361. [Google Scholar] [CrossRef] [PubMed]
  5. Carmona-Galindo, V.D.; Sheppard, C.C.; Bastin, M.L.; Kehrig, M.R.; Marín-Recinos, M.F.; Choi, J.J.; Castañeda de Abrego, V. Chromatic and Morphological Differentiation of Triatoma dimidiata (Hemiptera: Reduviidae) with Land Use Diversity in El Salvador. Pathogens 2021, 10, 753. [Google Scholar] [CrossRef] [PubMed]
  6. Ocaña-Mayorga, S.; Bustillos, J.J.; Villacís, A.G.; Pinto, C.M.; Brenière, S.F.; Grijalva, M.J. Triatomine Feeding Profiles and Trypanosoma cruzi Infection, Implications in Domestic and Sylvatic Transmission Cycles in Ecuador. Pathogens 2021, 10, 42. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Castillo, C.; Kemmerling, U. Host–Pathogen Interaction Involved in Trypanosoma cruzi Infection. Pathogens 2022, 11, 540. https://doi.org/10.3390/pathogens11050540

AMA Style

Castillo C, Kemmerling U. Host–Pathogen Interaction Involved in Trypanosoma cruzi Infection. Pathogens. 2022; 11(5):540. https://doi.org/10.3390/pathogens11050540

Chicago/Turabian Style

Castillo, Christian, and Ulrike Kemmerling. 2022. "Host–Pathogen Interaction Involved in Trypanosoma cruzi Infection" Pathogens 11, no. 5: 540. https://doi.org/10.3390/pathogens11050540

APA Style

Castillo, C., & Kemmerling, U. (2022). Host–Pathogen Interaction Involved in Trypanosoma cruzi Infection. Pathogens, 11(5), 540. https://doi.org/10.3390/pathogens11050540

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop